| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 727985 | NSC 708781 incorporated in micelles, 0.55% (w/w) of drug | 0.00526022686151165 | 0.18430134 |
| NSC 730460 | 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate | 0.00526022686151165 | 0.19007182 |
| NSC 750035 | Null | 0.00526022686151165 | 0.26476709 |
| NSC 755417 | Null | 0.00526022686151165 | -0.033605714 |
| NSC 150094 | 1-Azabicyclo[2.2.2]octan-3-one, 2-(4-morpholinylmethyl)- | 0.00526022686151168 | -0.032592424 |
| NSC 191909 | .alpha.-Chloro-N-(p-methoxyphenyl)succinimide | 0.00526022686151168 | 0.080901228 |
| NSC 212509 | Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) | 0.00526022686151168 | 0.34551947 |
| NSC 3053 | Actinomycin D | 0.00526022686151168 | 0.57907701 |
| NSC 306107 | 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester | 0.00526022686151168 | 0.41851173 |
| NSC 382770 | Null | 0.00526022686151168 | 0.17856733 |